Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Nonadherence to Hormonal Therapy in Breast Cancer

JAMA Oncol; 2016 Oct; Neugut, Zhong, Wright, et al

Women with breast cancer who were previously nonadherent to medications for chronic conditions tended to be the same way with oral hormonal therapy (HT), according to a retrospective cohort study involving more than 21,000 women.

Investigators defined medication nonadherence as a medication possession ratio less than 80%. Among the results:

  • ~16% of all patients were nonadherent.
  • Patients <55 or ≥75 years of age were more apt to be nonadherent, as were those with higher 30-day, out-of-pocket costs and increased comorbidities.
  • Women without prior medications for 1 of the chronic conditions (~4 in every 10) had an 18% nonadherence rate to HT.
  • Those who used 1 or more medication prior to HT and were adherent (43%) had a 10% nonadherence rate to HT.
  • Those who were nonadherent to their chronic medications (2 in every 10) had a 23% nonadherence rate to HT.

Citation:

Neugut A, Zhong X, Wright J, Accordino M, Yang J, Hershman D. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncol. 2016;2(10):1326-1332. doi: 10.1001/jamaoncol.2016.1291.